Viewing Study NCT05341557


Ignite Creation Date: 2025-12-24 @ 7:00 PM
Ignite Modification Date: 2026-01-02 @ 1:19 PM
Study NCT ID: NCT05341557
Status: RECRUITING
Last Update Posted: 2025-01-27
First Post: 2022-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module